External PhD candidate Erasmus School of Health Policy & Management Health Technology Assessment (HTA)
- Location
- Burg. Oudlaan 50, Rotterdam
- kuppen@eshpm.eur.nl
More information
‹ Back to overview
Profile
- Malou Kuppen, HM Westgeest, AJM Van den Eertwegh, J Coenen, RJA van Moorselaar, P Berg, MM Geenen, N Mehra, MP Hendriks, MI Lampe, ACM van de Luijtgaarden, FPJ Peters, TA Roeleveld, TJ Smilde, Ronald Wit, IM van Oort, WR Gerritsen & Carin Groot (2020) - Health-related Quality of Life and Pain in a Real-world Castration-resistant Prostate Cancer Population: Results From the PRO-CAPRI Study in the Netherlands - Clinical Genitourinary Cancer, 18 (3), E233-E253 - doi: 10.1016/j.clgc.2019.11.015
- S Schmid, A Omlin, C Higano, C Sweeney, NM Chanza, N Mehra, Malou Kuppen, H Beltran, V Condeduca, DVP de Almeida, FC Maluf, WK Oh, CK Tsao, O Sartor, E Ledet, G Di Lorenzo, SM Yip, KN Chi, D Bianchini, U De Giorgi, AR Hansen, TM Beer, L Pernelle, R Morales-Barrera, M Tucci, E Castro, K Karalis, AM Bergman, ML Le, U Zurrer-Hardi, C Pezaro, H Suzuki, A Zivi, D Klingbiel, S Schar & S Gillessen (2020) - Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations - JAMA network open, 3 (10) - doi: 10.1001/jamanetworkopen.2020.21692
- PHJ Slootbeek, ML Duizer, MJ Doelen, ISH Kloots, Malou Kuppen, HM Westgeest, Carin Groot, S Pamidimarri Naga, MJL Ligtenberg & IM van Oort (2020) - Impact of DNA damage repair defects and aggressive variant features on response to carboplatin-based chemotherapy in metastatic castration-resistant prostate cancer - International Journal of Cancer, 148 (2), 385-395 - doi: 10.1002/ijc.33306
- Kevin Veen, IB de Angst, Mostafa Mokhles, HM Westgeest, Malou Kuppen, Carin Groot, WR Gerritsen, PJM Kil & Hanneke Takkenberg (2020) - A clinician’s guide for developing a prediction model: a case study using real?world data of patients with castration?resistant prostate cancer - Journal of Cancer Research and Clinical Oncology, 146, 2067-2075 - doi: 10.1007/s00432-020-03286-8
- Malou C.P. Kuppen, H.M. (Hans) Westgeest, Maarten J. Van Der Doelen, Alphonsus J.M. Van Den Eertwegh, Jules L.L.M. Coenen, Katja K.H. Aben, Alphons C.M. Van Den Bergh, Andries M. Bergman, Joan Van Den Bosch, Filiz Celik, Mathijs P. Hendriks, Jules Lavalaye, Saskia Van Der Meer, Marco B. Polee, Diederik M. Somford, Inge M. Van Oort, Carin A. Uyl-De Groot & Winald R. Gerritsen (2020) - Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancer - Future Oncology, 16 (19), 1371-1384 - doi: 10.2217/fon-2020-0039
- Jessica C.L. Notohardjo, Malou C.P. Kuppen, Hans M. Westgeest, Reindert J.A. van Moorselaar, Niven Mehra, Jules L.L.M. Coenen, Inge M. van Oort, Aad I. de Vos, Walter L. Vervenne, Alphons C.M. van den Bergh, Katja K.H. Aben, Diederik M. Somford, Andries M. Bergman, Carin A. Uyl-de Groot, Winald R. Gerritsen & Alfons J.M. van den Eertwegh (2020) - Third-line Life-prolonging Drug Treatment in a Real-world Metastatic Castration-resistant Prostate Cancer Population - European Urology Focus - doi: 10.1016/j.euf.2020.03.009
- Hans Westgeest, Malou Kuppen, AJM Van den Eertwegh, Ronald Wit, J Coenen, HP van den Berg, N Mehra, IM van Oort, L Fossion, MP Hendriks, HJ Bloemendal, ACM van de Luijtgaarden, DT Huinink, ACM van den Bergh, JG Bosch, MB Polee, N Weijl, AM Bergman, Carin Groot & WR Gerritsen (2019) - Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI: Observational Study in the Netherlands - Clinical Genitourinary Cancer, 17 (5), E946-E956 - doi: 10.1016/j.clgc.2019.05.018
- Malou C.P. Kuppen, Hans M. Westgeest, Alphonsus J.M. van den Eertwegh, Reindert J.A. van Moorselaar, Inge M. van Oort, Juleon L.L.M. Coenen, A. C.M.Fons van den Bergh, Niven Mehra, Diederik M. Somford, Andre M. Bergman, Daan Ten Bokkel Huinink, Laurent Fossion, Maud M. Geenen, Mathijs P. Hendriks, Addy C.M. van de Luijtgaarden, Marco B. Polee, Nir I. Weijl, Agnes J. van de Wouw, Ronald de Wit, Carin A. Uyl-de Groot & Winald R. Gerritsen (2019) - Real-world Outcomes of Sequential Androgen-receptor Targeting Therapies with or Without Interposed Life-prolonging Drugs in Metastatic Castration-resistant Prostate Cancer - European urology oncology, 4 (4), 618-627 - doi: 10.1016/j.euo.2019.09.005 - [link]
- Malou Kuppen, HM Westgeest, AJM Van den Eertwegh, J Coenen, RJA van Moorselaar, P Berg, MM Geenen, N Mehra, MP Hendriks, MI Lampe, ACM van de Luijtgaarden, FPJ Peters, TA Roeleveld, TJ Smilde, Ronald Wit, IM van Oort, WR Gerritsen & Carin Groot (2020) - Health-related Quality of Life and Pain in a Real-world Castration-resistant Prostate Cancer Population: Results From the PRO-CAPRI Study in the Netherlands - Clinical Genitourinary Cancer, 18 (3), E233-E253 - doi: 10.1016/j.clgc.2019.11.015
- S Schmid, A Omlin, C Higano, C Sweeney, NM Chanza, N Mehra, Malou Kuppen, H Beltran, V Condeduca, DVP de Almeida, FC Maluf, WK Oh, CK Tsao, O Sartor, E Ledet, G Di Lorenzo, SM Yip, KN Chi, D Bianchini, U De Giorgi, AR Hansen, TM Beer, L Pernelle, R Morales-Barrera, M Tucci, E Castro, K Karalis, AM Bergman, ML Le, U Zurrer-Hardi, C Pezaro, H Suzuki, A Zivi, D Klingbiel, S Schar & S Gillessen (2020) - Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations - JAMA network open, 3 (10) - doi: 10.1001/jamanetworkopen.2020.21692
- PHJ Slootbeek, ML Duizer, MJ Doelen, ISH Kloots, Malou Kuppen, HM Westgeest, Carin Groot, S Pamidimarri Naga, MJL Ligtenberg & IM van Oort (2020) - Impact of DNA damage repair defects and aggressive variant features on response to carboplatin-based chemotherapy in metastatic castration-resistant prostate cancer - International Journal of Cancer, 148 (2), 385-395 - doi: 10.1002/ijc.33306
- Kevin Veen, IB de Angst, Mostafa Mokhles, HM Westgeest, Malou Kuppen, Carin Groot, WR Gerritsen, PJM Kil & Hanneke Takkenberg (2020) - A clinician’s guide for developing a prediction model: a case study using real?world data of patients with castration?resistant prostate cancer - Journal of Cancer Research and Clinical Oncology, 146, 2067-2075 - doi: 10.1007/s00432-020-03286-8
- Malou C.P. Kuppen, H.M. (Hans) Westgeest, Maarten J. Van Der Doelen, Alphonsus J.M. Van Den Eertwegh, Jules L.L.M. Coenen, Katja K.H. Aben, Alphons C.M. Van Den Bergh, Andries M. Bergman, Joan Van Den Bosch, Filiz Celik, Mathijs P. Hendriks, Jules Lavalaye, Saskia Van Der Meer, Marco B. Polee, Diederik M. Somford, Inge M. Van Oort, Carin A. Uyl-De Groot & Winald R. Gerritsen (2020) - Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancer - Future Oncology, 16 (19), 1371-1384 - doi: 10.2217/fon-2020-0039
- Jessica C.L. Notohardjo, Malou C.P. Kuppen, Hans M. Westgeest, Reindert J.A. van Moorselaar, Niven Mehra, Jules L.L.M. Coenen, Inge M. van Oort, Aad I. de Vos, Walter L. Vervenne, Alphons C.M. van den Bergh, Katja K.H. Aben, Diederik M. Somford, Andries M. Bergman, Carin A. Uyl-de Groot, Winald R. Gerritsen & Alfons J.M. van den Eertwegh (2020) - Third-line Life-prolonging Drug Treatment in a Real-world Metastatic Castration-resistant Prostate Cancer Population - European Urology Focus - doi: 10.1016/j.euf.2020.03.009
- Hans Westgeest, Malou Kuppen, AJM Van den Eertwegh, Ronald Wit, J Coenen, HP van den Berg, N Mehra, IM van Oort, L Fossion, MP Hendriks, HJ Bloemendal, ACM van de Luijtgaarden, DT Huinink, ACM van den Bergh, JG Bosch, MB Polee, N Weijl, AM Bergman, Carin Groot & WR Gerritsen (2019) - Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI: Observational Study in the Netherlands - Clinical Genitourinary Cancer, 17 (5), E946-E956 - doi: 10.1016/j.clgc.2019.05.018
- Malou C.P. Kuppen, Hans M. Westgeest, Alphonsus J.M. van den Eertwegh, Reindert J.A. van Moorselaar, Inge M. van Oort, Juleon L.L.M. Coenen, A. C.M.Fons van den Bergh, Niven Mehra, Diederik M. Somford, Andre M. Bergman, Daan Ten Bokkel Huinink, Laurent Fossion, Maud M. Geenen, Mathijs P. Hendriks, Addy C.M. van de Luijtgaarden, Marco B. Polee, Nir I. Weijl, Agnes J. van de Wouw, Ronald de Wit, Carin A. Uyl-de Groot & Winald R. Gerritsen (2019) - Real-world Outcomes of Sequential Androgen-receptor Targeting Therapies with or Without Interposed Life-prolonging Drugs in Metastatic Castration-resistant Prostate Cancer - European urology oncology, 4 (4), 618-627 - doi: 10.1016/j.euo.2019.09.005 - [link]
- Malou Kuppen, HM Westgeest, AJM Van den Eertwegh, J Coenen, RJA van Moorselaar, P Berg, MM Geenen, N Mehra, MP Hendriks, MI Lampe, ACM van de Luijtgaarden, FPJ Peters, TA Roeleveld, TJ Smilde, Ronald Wit, IM van Oort, WR Gerritsen & Carin Groot (2020) - Health-related Quality of Life and Pain in a Real-world Castration-resistant Prostate Cancer Population: Results From the PRO-CAPRI Study in the Netherlands - Clinical Genitourinary Cancer, 18 (3), E233-E253 - doi: 10.1016/j.clgc.2019.11.015
- S Schmid, A Omlin, C Higano, C Sweeney, NM Chanza, N Mehra, Malou Kuppen, H Beltran, V Condeduca, DVP de Almeida, FC Maluf, WK Oh, CK Tsao, O Sartor, E Ledet, G Di Lorenzo, SM Yip, KN Chi, D Bianchini, U De Giorgi, AR Hansen, TM Beer, L Pernelle, R Morales-Barrera, M Tucci, E Castro, K Karalis, AM Bergman, ML Le, U Zurrer-Hardi, C Pezaro, H Suzuki, A Zivi, D Klingbiel, S Schar & S Gillessen (2020) - Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations - JAMA network open, 3 (10) - doi: 10.1001/jamanetworkopen.2020.21692
- PHJ Slootbeek, ML Duizer, MJ Doelen, ISH Kloots, Malou Kuppen, HM Westgeest, Carin Groot, S Pamidimarri Naga, MJL Ligtenberg & IM van Oort (2020) - Impact of DNA damage repair defects and aggressive variant features on response to carboplatin-based chemotherapy in metastatic castration-resistant prostate cancer - International Journal of Cancer, 148 (2), 385-395 - doi: 10.1002/ijc.33306
- Kevin Veen, IB de Angst, Mostafa Mokhles, HM Westgeest, Malou Kuppen, Carin Groot, WR Gerritsen, PJM Kil & Hanneke Takkenberg (2020) - A clinician’s guide for developing a prediction model: a case study using real?world data of patients with castration?resistant prostate cancer - Journal of Cancer Research and Clinical Oncology, 146, 2067-2075 - doi: 10.1007/s00432-020-03286-8
- Malou C.P. Kuppen, H.M. (Hans) Westgeest, Maarten J. Van Der Doelen, Alphonsus J.M. Van Den Eertwegh, Jules L.L.M. Coenen, Katja K.H. Aben, Alphons C.M. Van Den Bergh, Andries M. Bergman, Joan Van Den Bosch, Filiz Celik, Mathijs P. Hendriks, Jules Lavalaye, Saskia Van Der Meer, Marco B. Polee, Diederik M. Somford, Inge M. Van Oort, Carin A. Uyl-De Groot & Winald R. Gerritsen (2020) - Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancer - Future Oncology, 16 (19), 1371-1384 - doi: 10.2217/fon-2020-0039
- Jessica C.L. Notohardjo, Malou C.P. Kuppen, Hans M. Westgeest, Reindert J.A. van Moorselaar, Niven Mehra, Jules L.L.M. Coenen, Inge M. van Oort, Aad I. de Vos, Walter L. Vervenne, Alphons C.M. van den Bergh, Katja K.H. Aben, Diederik M. Somford, Andries M. Bergman, Carin A. Uyl-de Groot, Winald R. Gerritsen & Alfons J.M. van den Eertwegh (2020) - Third-line Life-prolonging Drug Treatment in a Real-world Metastatic Castration-resistant Prostate Cancer Population - European Urology Focus - doi: 10.1016/j.euf.2020.03.009
- Hans Westgeest, Malou Kuppen, AJM Van den Eertwegh, Ronald Wit, J Coenen, HP van den Berg, N Mehra, IM van Oort, L Fossion, MP Hendriks, HJ Bloemendal, ACM van de Luijtgaarden, DT Huinink, ACM van den Bergh, JG Bosch, MB Polee, N Weijl, AM Bergman, Carin Groot & WR Gerritsen (2019) - Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI: Observational Study in the Netherlands - Clinical Genitourinary Cancer, 17 (5), E946-E956 - doi: 10.1016/j.clgc.2019.05.018
- Malou C.P. Kuppen, Hans M. Westgeest, Alphonsus J.M. van den Eertwegh, Reindert J.A. van Moorselaar, Inge M. van Oort, Juleon L.L.M. Coenen, A. C.M.Fons van den Bergh, Niven Mehra, Diederik M. Somford, Andre M. Bergman, Daan Ten Bokkel Huinink, Laurent Fossion, Maud M. Geenen, Mathijs P. Hendriks, Addy C.M. van de Luijtgaarden, Marco B. Polee, Nir I. Weijl, Agnes J. van de Wouw, Ronald de Wit, Carin A. Uyl-de Groot & Winald R. Gerritsen (2019) - Real-world Outcomes of Sequential Androgen-receptor Targeting Therapies with or Without Interposed Life-prolonging Drugs in Metastatic Castration-resistant Prostate Cancer - European urology oncology, 4 (4), 618-627 - doi: 10.1016/j.euo.2019.09.005 - [link]
Module Knowledge
- Level
- bachelor 1
- Year
- 2020
- Year Level
- bachelor 1
- Course Code
- GW104K
Module Knowledge
- Level
- bachelor 1
- Year
- 2020
- Year Level
- bachelor 1
- Course Code
- GW104K